Hansa Biopharma AB (publ) (HNSA.ST)
SEK 33.3
(17.42%)
SEK 33.3
(17.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -15.83 SEK | -16.4% |
| 2022 | -13.60 SEK | -10.3% |
| 2021 | -12.33 SEK | -23.55% |
| 2020 | -9.98 SEK | -10.89% |
| 2019 | -9.00 SEK | -39.1% |
| 2018 | -6.47 SEK | -30.18% |
| 2017 | -4.97 SEK | -47.48% |
| 2016 | -3.37 SEK | -58.96% |
| 2015 | -2.12 SEK | -94.5% |
| 2014 | -1.09 SEK | -51.39% |
| 2013 | -0.72 SEK | -1.41% |
| 2012 | -0.71 SEK | 66.35% |
| 2011 | -2.11 SEK | 7.05% |
| 2010 | -2.27 SEK | 27.24% |
| 2009 | -3.12 SEK | -511.76% |
| 2008 | -0.51 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -3.30 SEK | 20.48% |
| 2024 Q3 | -1.53 SEK | 53.64% |
| 2024 Q1 | -4.15 SEK | -75.85% |
| 2023 Q1 | -3.92 SEK | -21.74% |
| 2023 Q3 | -4.78 SEK | 0.21% |
| 2023 FY | - SEK | -16.4% |
| 2023 Q4 | -2.36 SEK | 50.63% |
| 2023 Q2 | -4.79 SEK | -22.19% |
| 2022 Q2 | -3.82 SEK | -22.83% |
| 2022 Q1 | -3.11 SEK | 15.49% |
| 2022 FY | - SEK | -10.3% |
| 2022 Q4 | -3.22 SEK | 6.67% |
| 2022 Q3 | -3.45 SEK | 9.69% |
| 2021 Q2 | -2.98 SEK | -27.35% |
| 2021 Q1 | -2.34 SEK | 1.68% |
| 2021 FY | - SEK | -23.55% |
| 2021 Q3 | -3.34 SEK | -12.08% |
| 2021 Q4 | -3.68 SEK | -10.18% |
| 2020 FY | - SEK | -10.89% |
| 2020 Q1 | -2.33 SEK | 15.88% |
| 2020 Q2 | -2.48 SEK | -6.44% |
| 2020 Q3 | -2.77 SEK | -11.69% |
| 2020 Q4 | -2.38 SEK | 14.08% |
| 2019 Q4 | -2.77 SEK | -17.37% |
| 2019 Q3 | -2.36 SEK | -14.56% |
| 2019 Q2 | -2.06 SEK | -13.81% |
| 2019 Q1 | -1.81 SEK | 12.56% |
| 2019 FY | - SEK | -39.1% |
| 2018 FY | - SEK | -30.18% |
| 2018 Q1 | -1.23 SEK | 8.21% |
| 2018 Q4 | -2.07 SEK | -28.57% |
| 2018 Q3 | -1.61 SEK | -3.87% |
| 2018 Q2 | -1.55 SEK | -26.02% |
| 2017 Q3 | -1.06 SEK | 17.19% |
| 2017 Q4 | -1.34 SEK | -26.42% |
| 2017 FY | - SEK | -47.48% |
| 2017 Q1 | -1.27 SEK | -32.29% |
| 2017 Q2 | -1.28 SEK | -0.79% |
| 2016 Q1 | -0.61 SEK | -3.39% |
| 2016 FY | - SEK | -58.96% |
| 2016 Q3 | -0.83 SEK | 11.7% |
| 2016 Q4 | -0.96 SEK | -15.66% |
| 2016 Q2 | -0.94 SEK | -54.1% |
| 2015 FY | - SEK | -94.5% |
| 2015 Q1 | -0.39 SEK | 23.53% |
| 2015 Q3 | -0.43 SEK | 38.57% |
| 2015 Q2 | -0.70 SEK | -79.49% |
| 2015 Q4 | -0.59 SEK | -37.21% |
| 2014 Q3 | -0.20 SEK | -11.11% |
| 2014 Q4 | -0.51 SEK | -155.0% |
| 2014 Q1 | -0.26 SEK | -44.44% |
| 2014 Q2 | -0.18 SEK | 30.77% |
| 2014 FY | - SEK | -51.39% |
| 2013 Q3 | -0.18 SEK | 5.26% |
| 2013 Q2 | -0.19 SEK | 0.0% |
| 2013 Q4 | -0.18 SEK | 0.0% |
| 2013 Q1 | -0.19 SEK | -18.75% |
| 2013 FY | - SEK | -1.41% |
| 2012 Q4 | -0.16 SEK | 0.0% |
| 2012 FY | - SEK | 66.35% |
| 2011 FY | - SEK | 7.05% |
| 2010 FY | - SEK | 27.24% |
| 2009 FY | - SEK | -511.76% |
| 2008 FY | - SEK | 0.0% |